Therapeutic agent for pancreatic cancer and/or biliary tract cancer
AssigneesAjinomoto Co., Inc., National University Corporation Kochi University
InventorsShinobu NISHITANI, Kazuhiro HANAZAKI, Toshiji SAIBARA
Life of this patent
Estimating the term…
Abstract
The problem of the present invention is to provide a highly effective therapeutic drug for pancreatic cancer and/or biliary tract cancer. A therapeutic drug for pancreatic cancer and/or biliary tract cancer containing the following (1) and (2) as essential components: (1) at least one kind of branched-chain amino acid selected from the group consisting of isoleucine, leucine and valine, (2) gemcitabine or a salt thereof.
Claims24
A therapeutic drug, comprising:
- (1) at least one kind of branched-chain amino acid selected from the group consisting of isoleucine, leucine, and valine;
- and
- (2) gemcitabine or a salt thereof.
A method for enhancing an anticancer activity of gemcitabine or a salt thereof against pancreatic cancer and/or biliary tract cancer, comprising administering to a subject in need thereof an effective amount of at least one kind of branched-chain amino acid selected from the group consisting of isoleucine, leucine, and valine.
A method of treating pancreatic cancer and/or biliary tract cancer, comprising administering to a subject in need thereof an effective amount of:
- (1) at least one kind of branched-chain amino acid selected from the group consisting of isoleucine, leucine, and valine;
- and
- (2) gemcitabine or a salt thereof.
Dependencies are inferred from the claim text.